CAS 2270984-21-7

4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)-

Description:

4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)- is a chemical compound characterized by its complex structure, which includes a quinazolinamine core and a benzodioxin moiety. This compound features a pyridine ring, contributing to its potential biological activity. The presence of the benzodioxin group suggests possible interactions with biological targets, making it of interest in medicinal chemistry. The compound's molecular structure indicates it may exhibit specific pharmacological properties, potentially acting as an inhibitor or modulator in various biochemical pathways. Its solubility, stability, and reactivity would depend on the functional groups present and the overall molecular conformation. As with many organic compounds, the synthesis and characterization of this substance would involve techniques such as NMR spectroscopy, mass spectrometry, and possibly X-ray crystallography to confirm its structure and purity. Further studies would be necessary to elucidate its biological activity and potential applications in drug development.

Formula: C₂₃H₂₀N₄O₂

Synonyms:

• Gcase activator 3
• 4-Quinazolinamine, N-[[(2S)-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)-

Gcase activator 3

CAS: 2270984-21-7

Gcase activator 3

Purity: ≥98%

Molecular weight: 384.43g/mol

Ref: 54-BUP20204

Gcase activator 3

CAS: 2270984-21-7

Gcase activator 3 is a glucocerebrosidase (GCase) activator that enhances GBA1 mutant fibroblast lysosomal GCase activity.

Formula: C₂₃H₂₀N₄O₂

Purity: 99.08%

Color and Shape: Solid

Molecular weight: 384.43

Ref: TM-T86496